Patents by Inventor Nicholas D. Smith
Nicholas D. Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8609852Abstract: The identification of a unique series of compounds which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the selection of a 1,3-thiazol-2-yl ring member linked by an ethynylene to the 3 position of a pyridyl ring or the 5 position of a pyrimidinyl ring, wherein the ring is substituted with selected substituents, results in a compound having superior drug-like properties. The invention includes pharmaceutically acceptable salt forms of these heterocyclic compounds, in particular chloride salts and trifluoroacetate salts.Type: GrantFiled: July 26, 2012Date of Patent: December 17, 2013Assignee: Merck Sharp & Dohme Corp.Inventors: Nicholas D. Cosford, Thomas J. Seiders, Joseph E. Payne, Jeffrey R. Roppe, Dehua Huang, Nicholas D. Smith, Steve F. Poon, Chris King, Brian W. Eastman, Bowei Wang, Jeannie M. Arruda, Jean-Michel Vernier, Xiumin Zhao
-
Publication number: 20130244844Abstract: An exercise table which finds use in Pilates exercising includes an outer framework, a slidably movable support platform, and a foot bar against which a user's feet can be engaged while sliding the support platform against the bias of springs by extending and retracting the user's legs. The frame has supporting legs which are tapered inwardly and downwardly so that one exercise table can be nestably stacked on another by inserting the tapered legs of an overlying exercise table through an opening in the frame of an underlying table until the frames themselves are closely adjacent. The foot bar, shoulder blocks, and pulleys used in operation of the table are also movable between elevated use positions and lowered storage positions to facilitate closely adjacent nestable stacking of identical exercise tables. Various systems are disclosed for accommodating different sized individuals while retaining desired resistance from resilient elements incorporated into the table.Type: ApplicationFiled: February 28, 2013Publication date: September 19, 2013Inventors: Howard Jay Solow, Julie Lobdell, Nicholas D. Smith, Chad Follmar, Jeffery T. Samson, Nicholas Aldo Nespeca
-
Publication number: 20130231333Abstract: Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.Type: ApplicationFiled: September 15, 2011Publication date: September 5, 2013Applicant: ARAGON PHARMACEUTICALS, INC.Inventors: Nicholas D. Smith, Mehmet Kahraman, Steven P. Govek, Johnny Y. Nagasawa, Andiliy G. Lai, Jackaline D. Julien, Mark R. Herbert, Celine Bonnefous, Karensa L. Douglas
-
Patent number: 8455534Abstract: Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.Type: GrantFiled: September 13, 2012Date of Patent: June 4, 2013Assignee: Aragon Pharmaceuticals, Inc.Inventors: Nicholas D. Smith, Mehmet Kahraman, Steven P. Govek, Johnny Y. Nagasawa, Andiliy G. Lai, Jackaline D. Julien, Celine Bonnefous
-
Publication number: 20130137746Abstract: Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.Type: ApplicationFiled: June 15, 2011Publication date: May 30, 2013Applicant: ARAGON PHARMACEUTICALS, INC.Inventors: Steven P. Govek, Nicholas D. Smith
-
Publication number: 20130116258Abstract: Described herein are compounds that are androgen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such androgen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon androgen receptors.Type: ApplicationFiled: February 16, 2011Publication date: May 9, 2013Applicant: ARAGON PHARMACEUTICALS, INC.Inventors: Nicholas D. Smith, Celine Bonnefous, Jackaline D. Julien
-
Publication number: 20130116232Abstract: Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.Type: ApplicationFiled: June 8, 2011Publication date: May 9, 2013Applicant: ARAGON PHARMACEUTICALS, INC.Inventors: Mehmet Kahraman, Steven P. Govek, Johnny Y. Nagasawa, Nicholas D. Smith
-
Patent number: 8394005Abstract: An exercise table which finds use in Pilates exercising includes an outer framework, a slidably movable support platform, and a foot bar against which a user's feet can be engaged while sliding the support platform against the bias of springs by extending and retracting the user's legs. The frame has supporting legs which are tapered inwardly and downwardly so that one exercise table can be nestably stacked on another by inserting the tapered legs of an overlying exercise table through an opening in the frame of an underlying table until the frames themselves are closely adjacent. The foot bar, shoulder blocks, and pulleys used in operation of the table are also movable between elevated use positions and lowered storage positions to facilitate closely adjacent nestable stacking of identical exercise tables. Various systems are disclosed for accommodating different sized individuals while retaining desired resistance from resilient elements incorporated into the table.Type: GrantFiled: September 8, 2009Date of Patent: March 12, 2013Assignee: Mad Dogg Athletics, Inc.Inventors: Howard Jay Solow, Julie Lobdell, Nicholas D. Smith, Chad Follmar, Jeffery T. Samson, Nicholas Aldo Nespeca
-
Publication number: 20130012561Abstract: Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.Type: ApplicationFiled: September 13, 2012Publication date: January 10, 2013Applicant: ARAGON PHARMACEUTICALS, INC.Inventors: Nicholas D. SMITH, Mehmet Kahraman, Steven P. Govek, Johnny Y. Nagasawa, Andiliy G. Lai, Jackaline D. Julien, Celine Bonnefous
-
Publication number: 20120289696Abstract: The identification of a unique series of compounds which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the selection of a 1,3-thiazol-2-yl ring member linked by an ethynylene to the 3 position of a pyridyl ring or the 5 position of a pyrimidinyl ring, wherein the ring is substituted with selected substituents, results in a compound having superior drug-like properties. The invention includes pharmaceutically acceptable salt forms of these heterocyclic compounds, in particular chloride salts and trifluoroacetate salts.Type: ApplicationFiled: July 26, 2012Publication date: November 15, 2012Inventors: Nicholas D. Cosford, Thomas J. Seiders, Joseph E. Payne, Jeffrey R. Roppe, Dehua Huang, Nicholas D. Smith, Steve F. Poon, Chris King, Brian W. Eastman, Bowei Wang, Jeannie M. Arruda, Jean-Michel Vernier, Xiumin Zhao
-
Patent number: 8299112Abstract: Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.Type: GrantFiled: September 15, 2011Date of Patent: October 30, 2012Assignee: Aragon Pharmaceuticals, Inc.Inventors: Nicholas D. Smith, Mehmet Kahraman, Steven P. Govek, Johnny Y. Nagasawa, Andiliy G. Lai, Jackaline D. Julien, Celine Bonnefous
-
Patent number: 8242143Abstract: The identification of a unique series of compounds which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the selection of a 1,3-thiazol-2-yl ring member linked by an ethynylene to the 3 position of a pyridyl ring or the 5 position of a pyrimidinyl ring, wherein the ring is substituted with selected substituents, results in a compound having superior drug-like properties. The invention includes pharmaceutically acceptable salt forms of these heterocyclic compounds, in particular chloride salts and trifluoroacetate salts.Type: GrantFiled: January 28, 2011Date of Patent: August 14, 2012Assignee: Merck Sharp & Dohme Corp.Inventors: Nicholas D. Cosford, Thomas J. Seiders, Joseph Payne, Jeffrey R. Roppe, Dehua Huang, Nicholas D. Smith, Steve F. Poon, Chris King, Brian W. Eastman, Bowei Wang, Jeannie M. Arruda, Jean-Michel Vernier, Xiumin Zhao
-
Publication number: 20120071535Abstract: Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.Type: ApplicationFiled: September 15, 2011Publication date: March 22, 2012Applicant: Aragon Pharmaceuticals, Inc.Inventors: Nicholas D. SMITH, Mehmet KAHRAMAN, Steven P. GOVEK, Johnny Y. NAGASAWA, Andiliy G. LAI, Jackaline D. Julien, Celine Bonnefous
-
Publication number: 20110230526Abstract: The identification of a unique series of compounds which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the selection of a 1,3-thiazol-2-yl ring member linked by an ethynylene to the 3 position of a pyridyl ring or the 5 position of a pyrimidinyl ring, wherein the ring is substituted with selected substituents, results in a compound having superior drug-like properties. The invention includes pharmaceutically acceptable salt forms of these heterocyclic compounds, in particular chloride salts and trifluoroacetate salts.Type: ApplicationFiled: January 28, 2011Publication date: September 22, 2011Applicant: Merck Sharp & Dohme Corp.Inventors: Nicholas D. Cosford, Thomas J. Seiders, Joseph E. Payne, Jeffrey R. Roppe, Dehua Huang, Nicholas D. Smith, Steve F. Poon, Chris King, Brian W. Eastman, Bowei Wang, Jeannie M. Arruda, Jean-Michel Vernier, Xiumin Zhao
-
Patent number: 7879882Abstract: The identification of a unique series of compounds which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the selection of a 1,3-thiazol-2-yl ring member linked by an ethynylene to the 3 position of a pyridyl ring or the 5 position of a pyrimidinyl ring, wherein the ring is substituted with selected substituents, results in a compound having superior drug-like properties. The invention includes pharmaceutically acceptable salt forms of these heterocyclic compounds, in particular chloride salts and trifluoroacetate salts.Type: GrantFiled: October 6, 2005Date of Patent: February 1, 2011Assignee: Merck Sharp & Dohme Corp.Inventors: Nicholas D. Cosford, Thomas J. Seiders, Joseph E. Payne, Jeffrey R. Roppe, Dehua Huang, Nicholas D. Smith, Steve F. Poon, Chris King, Brian W. Eastman, Bowei Wang, Jeannie M. Arruda, Jean-Michel Vernier, Xiumin Zhao
-
Publication number: 20100004101Abstract: An exercise table which finds use in Pilates exercising includes an outer framework, a slidably movable support platform, and a foot bar against which a user's feet can be engaged while sliding the support platform against the bias of springs by extending and retracting the user's legs. The frame has supporting legs which are tapered inwardly and downwardly so that one exercise table can be nestably stacked on another by inserting the tapered legs of an overlying exercise table through an opening in the frame of an underlying table until the frames themselves are closely adjacent. The foot bar, shoulder blocks, and pulleys used in operation of the table are also movable between elevated use positions and lowered storage positions to facilitate closely adjacent nestable stacking of identical exercise tables. Various systems are disclosed for accommodating different sized individuals while retaining desired resistance from resilient elements incorporated into the table.Type: ApplicationFiled: September 8, 2009Publication date: January 7, 2010Inventors: Howard Jay Solow, Julie Lobdell, Nicholas D. Smith, Chad Follmar, Jeffery T. Samson, Nicholas Aldo Nespeca
-
Patent number: 7592337Abstract: Tetrazole compounds substituted directly, or by a bridge, with i) a heteroaryl moiety containing N adjacent to the point of connection of the heteroaryl and ii) another heteroaryl or aryl ring, with at least one of the rings being further substituted with another ring, are mGluR5 modulators useful in the treatment of psychiatric and mood disorders such as, for example, schizophrenia, anxiety, depression, panic, and bipolar disorder, as well as in the treatment of pain, Parkinson's disease, cognitive dysfunction, epilepsy, circadian rhythm disorders, drug addiction, drug abuse, drug withdrawal, obesity and other diseases.Type: GrantFiled: March 7, 2003Date of Patent: September 22, 2009Assignee: Merck & Co., Inc.Inventors: Chixu Chen, Nicholas D. P. Cosford, Brian W. Eastman, Dehua Huang, Steve F. Poon, Thomas S. Reger, Jeffrey R. Roppe, Nicholas D. Smith
-
Publication number: 20090203903Abstract: The identification of a unique series of compounds which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the selection of a 1,3-thiazol-2-yl ring member linked by an ethynylene to the 3 position of a pyridyl ring or the 5 position of a pyrimidinyl ring, wherein the ring is substituted with selected substituents, results in a compound having superior drug-like properties. The invention includes pharmaceutically acceptable salt forms of these heterocyclic compounds, in particular chloride salts and trifluoroacetate salts.Type: ApplicationFiled: October 6, 2005Publication date: August 13, 2009Inventors: Nicholas D. Cosford, Thomas J. Seiders, Joseph Payne, Jeffrey R. Roppe, Dehua Huang, Nicholas D. Smith, Steve F. Poon, Chris King, Brian W. Eastman, Bowei Wang, Jeannie M. Arruda, Jean-Michel Vernier, Xiumin Zhao
-
Patent number: 7569592Abstract: Pyrazole compounds substituted directly, or by a bridge, with a heteroaryl moiety containing N adjacent to the point of connection of the heteroaryl, are mGluR5 modulators useful in the treatment of psychiatric and mood disorders such as, for example, schizophrenia, anxiety, depression, bipolar disorder and panic, as well as in the treatment of pain, circadian rhythm disorders, and other diseases.Type: GrantFiled: December 13, 2002Date of Patent: August 4, 2009Assignee: Merck & Co., Inc.Inventors: Nicholas D. P. Cosford, Chixu Chen, Brian W. Eastman, Dehua Huang, Benito Munoz, Petpiboon Prasit, Nicholas D. Smith
-
Publication number: 20090105124Abstract: Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of modulation of TGR5 activity in a human or animal subject are also provided for the treatment diseases mediated by TGR5.Type: ApplicationFiled: August 18, 2008Publication date: April 23, 2009Applicant: Kalypsys, Inc.Inventors: Nicholas D. Smith, Joseph E. Payne, Timothy Z. Hoffman, Celine Bonnefous, Anothony B. Pinkerton, Dana L. Siegel